Clinical Trials

Find a Trial

Trial Summary

Protocol No.PHO-COG-FALLON-ANBL00B1
StatusOPEN TO ACCRUAL
Principal InvestigatorPradhan, Kamnesh
ScopeNational
PhaseNA
Age GroupChildren
TitleNeuroblastoma Biology Studies
DescriptionThis research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
Key EligibilityIn order to be eligible to take part in this trial, patients must meet the following criteria:

  • All newly diagnosed patients with suspected neuroblastoma, suspected ganglioneuroblastoma, or suspected ganglioneuroma/maturing subtype seen at Children's Oncology Group (COG) institutions are eligible for this study
  • Patients may not have received chemotherapy prior to enrollment on ANBL00B1 and procurement of study-related tissues with the following exception:
    • Patients that in the opinion of the treating physician are too ill to undergo pre-treatment tissue biopsy and require EMERGENT chemotherapy may be enrolled on ANBL00B1; documentation of the emergent nature of therapy initiation is required
For a full list of participation criteria, please visit ClinicalTrials.gov.
Applicable Disease SitesChildhood Cancers
Neuroblastoma (Child)
Participating InstitutionsIndiana University (IU)
  • Indiana University Hospital / IU Simon Cancer Center
  • Riley Hospital for Children
Treatment TypeBasic Science
Contact[unknown] Pediatric Research, Phone: +1 317-944-8784
Pager:
Email: